Universal Health Services, Inc.
UHS · NYSE
Company research
Universal Health Services, Inc. (NYSE: UHS) is one of the largest and most respected providers of hospital and healthcare services in the United States, founded in 1979 by Alan B. Miller and headquartered in King of Prussia, Pennsylvania. Under the leadership of President and CEO Marc D. Miller, UHS operates through two primary segments — Acute Care Hospital Services and Behavioral Health Care Services — with a network spanning 29 inpatient acute care hospitals, 346 inpatient behavioral health facilities, and over 160 outpatient and ambulatory care sites across 40 U.S. states, Washington D.C., Puerto Rico, and the United Kingdom, making it the nation's largest owner of freestanding inpatient psychiatric hospitals. The company, a Fortune 300 corporation with approximately 99,000 employees, reported $15.8 billion in revenues for 2024, treating approximately 3.7 million patients, and further extends its reach through health insurance offerings via Prominence Health and physician management services through Independence Physician Management. UHS also serves as advisor to Universal Health Realty Income Trust (NYSE: UHT), a real estate investment trust, and carries a current market capitalization of approximately $9.3 billion.
Research reports
MarketBeat · July 8, 2026Universal Health Services (UHS) Stock Price, News & Analysis $UHS
This MarketBeat stock analysis provides a consensus Hold rating, a one-year price target of $216.56 implying about 34% upside, and highlights UHS’s low P/E multiple versus both the broader market and medical sector, alongside strong institutional ownership and modest dividend payout.
Simply Wall St · June 23, 2026Universal Health Services (NYSE:UHS) - Stock AnalysisSimply Wall St’s fundamental report emphasizes that UHS trades at a large discount to its estimated fair value, with strong past earnings growth and solid profitability, while noting elevated debt levels and policy-related risks that could pressure margins but are partly offset by resilient demand and analyst expectations for future upside.
StockStory · March 30, 2026Universal Health Services (UHS) Research Report: Q4 CY2025 UpdateStockStory’s Q4 CY2025 research report frames UHS as an “Investable Timely Buy,” citing roughly 9% revenue growth, improving free cash flow margins, solid ROIC, and a consensus price target implying around 35% upside, while acknowledging softer same-store sales, labor cost pressures, and policy/reimbursement risks that investors must monitor.
ChartMill · December 24, 2025UHS Fundamental Analysis - UNIVERSAL HEALTH SERVICES-BChartMill’s fundamental analysis rates UHS 6/10 overall, stressing strong profitability metrics and particularly attractive valuation, including a low P/E and EV/sales that support an “undervalued” conclusion suitable for value investing, though it flags only moderate balance sheet strength and the need to watch leverage and liquidity metrics.
Accountable.finance · December 8, 2025Universal Health Services Inc (UHS) Stock: Fundamentals & Strategy InsightsAccountable’s AI-driven fundamentals and strategy report presents a clear bull thesis around deep value at a single-digit P/E, high ROE, and strong EPS and FCF metrics, balanced by a bear case focused on sizeable debt, interest expense sensitivity, and goodwill concentration, and lays out explicit margin-expansion and capital-allocation triggers for the forward outlook.